Media headlines about Scpharmaceuticals (NASDAQ:SCPH) have been trending somewhat negative this week, according to Accern Sentiment Analysis. The research firm scores the sentiment of media coverage by analyzing more than 20 million news and blog sources. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Scpharmaceuticals earned a daily sentiment score of -0.06 on Accern’s scale. Accern also assigned news coverage about the company an impact score of 46.6062207915599 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the next few days.
A number of research analysts have issued reports on the stock. Zacks Investment Research downgraded shares of Scpharmaceuticals from a “hold” rating to a “sell” rating in a research report on Wednesday, February 14th. Jefferies Group assumed coverage on shares of Scpharmaceuticals in a research report on Tuesday, December 12th. They set a “buy” rating and a $23.00 price objective on the stock. Leerink Swann assumed coverage on shares of Scpharmaceuticals in a research report on Tuesday, December 12th. They set an “outperform” rating and a $20.00 price objective on the stock. Finally, BMO Capital Markets assumed coverage on shares of Scpharmaceuticals in a research report on Tuesday, December 12th. They set an “outperform” rating and a $24.00 price objective on the stock.
Shares of Scpharmaceuticals (NASDAQ:SCPH) traded up $0.35 during mid-day trading on Friday, hitting $15.35. 19,809 shares of the stock were exchanged, compared to its average volume of 30,232. Scpharmaceuticals has a 1 year low of $11.50 and a 1 year high of $18.17.
ILLEGAL ACTIVITY WARNING: “Scpharmaceuticals (SCPH) Earns Daily News Impact Rating of -0.06” was originally reported by Transcript Daily and is the property of of Transcript Daily. If you are reading this piece on another domain, it was illegally stolen and republished in violation of US and international copyright legislation. The original version of this piece can be accessed at https://transcriptdaily.com/2018/02/25/scpharmaceuticals-scph-earns-daily-news-impact-rating-of-0-06.html.
scPharmaceuticals, Inc, is a biopharmaceutical company. The Company is engaged in developing pharmaceutical products for subcutaneous delivery. The Company offers sc2Wear Infusor, which is a small pump that attaches to the body using a standard medical adhesive. The sc2Wear Infusor injects the drug into the body slowly, similar to an intravenous (IV) drip.
Receive News & Ratings for Scpharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Scpharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.